US Healthcare provider HCA inaugurates Global Capability Centre in Hyderabad

IMT News Desk
IMT News Desk
· 2 min read

US-based healthcare services provider- HCA Healthcare has inaugurated its first Global Capability Center (GCC) in Hyderabad with plans to invest USD 75 million by the end of 2025 and create 3,000 jobs by 2026.

The new Hyderabad facility, spanning over 400,000 sq.ft., will operate under HCA Healthcare – India and focus on strengthening talent across critical functions such as IT, supply chain, procurement, human resources, finance, and accounting. The center is expected to play a key role in supporting HCA Healthcare’s operations in the United States and the United Kingdom, according to the company statement.

The inauguration was led by Telangana IT and Industries Minister D Sridhar Babu, who was joined by Emily Duncan, Senior Vice President, Global Capability Network, HCA Healthcare, and Atul Kapoor, Vice President and Hyderabad Center Head, HCA Healthcare – India.

“We are proud to welcome HCA Healthcare’s first Global Capability Center in India, a strong endorsement of Hyderabad’s leadership and a milestone that will further accelerate our journey as a global hub for healthcare and innovation,” Sridhar Babu said.

Emily Duncan said the Hyderabad launch emphasizes the company’s commitment to developing global capabilities from India.

HCA Healthcare operates a network of 192 hospitals and 2,500 care sites across the U.S. and the United Kingdom. A part of the Fortune 100 list of companies, it employs 3,16,000 professionals and reported USD 70 billion in revenue.

Read Next

Alembic Pharmaceuticals Limited announces USFDA Tentative Approval for Larotrectinib Capsules
News
June 11, 2026

Alembic Pharmaceuticals Limited announces USFDA Tentative Approval for Larotrectinib Capsules

Alembic Pharmaceuticals Limited (Alembic) announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Larotrectinib Capsules, 25 mg and 100 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Vitrakvi Capsules, 25 mg and 100 mg, of […]
Article by: IMT News Desk
DFE Pharma earns third consecutive EcoVadis Gold Medal for sustainability performance 
News
June 11, 2026

DFE Pharma earns third consecutive EcoVadis Gold Medal for sustainability performance 

DFE Pharma has earned its third consecutive Gold Medal from EcoVadis, the world leader in corporate sustainability assessments, in recognition of its strong performance in the four themes rated: Environment, Labor & Human Rights, Ethics and Sustainable Procurement. This distinction places DFE Pharma in the top 5% of companies, reflecting the company’s focused efforts to […]
Article by: IMT News Desk
Oval Fertility Inks MoU with Merck to Advance Reproductive Care Standards in India
News
June 11, 2026

Oval Fertility Inks MoU with Merck to Advance Reproductive Care Standards in India

Oval Advanced Fertility Care and Merck Specialities Private Limited, the Indian healthcare arm of Merck KGaA, Darmstadt, Germany and a global leader in fertility sciences with decades of scientific leadership in reproductive medicine, have signed a strategic Memorandum of Understanding (MOU).   India’s IVF market, valued at approximately USD 2.35 billion in 2024, is projected […]
Article by: IMT News Desk
Infosys-backed 4baseCare raises ₹128 crore, plans to take its cancer testing platform global
News
June 11, 2026

Infosys-backed 4baseCare raises ₹128 crore, plans to take its cancer testing platform global

Bengaluru-based precision oncology startup 4baseCare has raised ₹128 crore in its ongoing Series B funding round to expand its hospital-linked genomics laboratory network globally and scale its AI-powered precision oncology platform, OncoTwin. The latest funding round, which follows a first close of ₹90 crore co-led by Ashish Kacholia and Lashit Sanghvi with participation from existing […]
Article by: IMT News Desk